MedPath

KANSAI MEDICAL UNIVERSITY

πŸ‡―πŸ‡΅Japan
Ownership
Private
Established
1928-01-01
Employees
-
Market Cap
-
Website
http://www.kmu.ac.jp

Clinical Trials

138

Active:0
Completed:79

Trial Phases

4 Phases

Phase 1:4
Phase 2:5
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (137 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
127 (92.7%)
Phase 2
5 (3.6%)
Phase 1
4 (2.9%)
Phase 3
1 (0.7%)

Characterization of Macroprolactinemia

Completed
Conditions
Hyperprolactinemia
First Posted Date
2007-02-16
Last Posted Date
2007-02-16
Lead Sponsor
Kansai Medical University
Registration Number
NCT00436111
Locations
πŸ‡―πŸ‡΅

Kansai Medical University, Osaka, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.